Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome

Layla Mathieson,Lilian Koppensteiner,David A. Dorward,Richard A. O’Connor,Ahsan R. Akram,Richard A. O'Connor
DOI: https://doi.org/10.1038/s41416-024-02671-1
2024-04-07
BJC Reports
Abstract:Cancer-associated fibroblasts (CAFs) are a dominant cell type in the stroma of non-small cell lung cancer (NSCLC). Fibroblast heterogeneity reflects subpopulations of CAFs, which can influence prognosis and treatment efficacy. We describe the subtypes of CAFs in NSCLC.
English Else
What problem does this paper attempt to address?